Clinical trials
Phase 2 Pathologic Complete Response trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barwon Health | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Guangdong Provincial People's Hospital | 1 |
| Instituto Nacional de Cancerologia de Mexico | 1 |
| Jianhua Fu | 1 |
| National Taiwan University Hospital | 1 |
| Ottawa Hospital Research Institute | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Xuejie Jiang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Complete Response | 9 |
| Breast Neoplasms | 6 |
| Triple Negative Breast Neoplasms | 2 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Leukemia, Myeloid | 1 |
| Leukemia, Myeloid, Acute | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.